Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
St Jude Children’s Hospital was founded based on the mission “to find cures for children with catastrophic diseases through research and treatment.” The Pharmaceutical Department at St Jude strives to mirror this unique institutional commitment by providing the best pharmaceutical care required for each child at St Jude while supporting a collective research endeavor.
St Jude Children’s Research Hospital offers three different 12-month specialized residency (PGY2) opportunities. Currently St. Jude offers PGY2 residencies in Pediatric Hematology and Oncology (ASHP accredited), Clinical Pharmacogenetics and Medication-Use Safety.
During their various programs, the PGY2 residents will have the opportunity to learn, contribute and participate in a dynamic environment that consists of professional and technical personnel in both patient care and pharmaceutical research. Pediatric Hematology-Oncology and Clinical Pharmacogenetics Residents are provided training in applied pharmacokinetics, nutrition support, and advanced training in clinical therapeutics of the pediatric cancer patient, pharmacogenetics and medication-use safety. Medication-Use Safety Residents are provided advanced training in medication safety and medication use policy.
Depending on the residency program, the resident will have the opportunity to: participate in direct patient care responsibilities,help precept Doctor of Pharmacy students through the University of Tennessee College of Pharmacy; provide didactic lectures, in-services, journal clubs; and participate in Pharmacy and Therapeutics committee, as well as conduct collaborative clinical research. Residents will be expected to complete a research project during the year and present their findings at a national meeting.
